biotech | pharma | diagnostics | devices
biotech | pharma | diagnostics | devices
Idogen - Crunchbase Company Profile & Funding
Idogen - Engineering Immune Tolerance
Board and Advisors | Ambulero
Idogen's cell technology successfully advanced to large-scale production
Idogen appoints Anders Karlsson as new CEO - Idogen
Q3 ENG - Idogen
Investors Home
Idogen files patent application for new tolerogenic cell therapy
BioInsights - Bringing advanced therapies to the clinic: the Swedish National ATMP Consortium (CAMP/SWElife ATMP)
Idogen AB (publ)
niklas wallett - Idogen
Idogen AB (publ) Corp. Reg. No.
Idogen aktieägargrupp | Facebook
Idogen AB publicerar Årsredovisning för 2018
biotech | pharma | diagnostics | devices
Noteringar i veckan
Idogen - Crunchbase Company Profile & Funding
Trading Direkt analyserar bolagen på Spotlight 2018-10-18: Plejd & Idogen - YouTube
Idogen AB | Aktiespararna
Idogen Year end report 3 - Idogen
Idogen will be listed on Nasdaq First North Growth Market on June 4, 2020
